[Federal Register Volume 60, Number 160 (Friday, August 18, 1995)]
[Notices]
[Page 43156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-20565]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 91N-0450]
Guideline for Quality Assurance in Blood Establishments;
Availability; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a notice
that appeared in the Federal Register of July 14, 1995 (60 FR 36290).
The document announced the availability of a guideline entitled
``Guideline for Quality Assurance in Blood Establishments.'' The
guideline is intended to assist manufacturers of blood and blood
components in developing quality assurance (QA) programs that are
consistent with recognized principles of QA and current good
manufacturing practice. The document was published with some errors.
This document corrects those errors.
FOR FURTHER INFORMATION CONTACT: Sharon A. Carayiannis, Center for
Biologics Evaluation and Research (HFM-635), Food and Drug
Administration,-1401 Rockville Pike, Rockville, MD 20852, 301-594-3074.
In FR Doc. 95-17346, appearing on page 36290 in the Federal
Register of Friday, July 14, 1995, the following corrections are made:
On page 36290, in the second column, under the ADDRESSES caption,
in lines 25 and 34, ``CDV2.CBER.FDA.GOV'' is corrected to read
``CDVS2.CDER.FDA.GOV'', and on the same page, in the third column,
under the SUPPLEMENTARY INFORMATION caption, in line 23, ``July 14,
1995,'' is corrected to read ``July 11, 1995''.
Dated: August 14, 1995.
William K. Hubbard,
Acting Deputy Commissioner for Policy.
[FR Doc. 95-20565 Filed 8-17-95; 8:45 am]
BILLING CODE 4160-01-F
